Calcium channel blockers ameliorate disease in a mouse model of multiple sclerosis
- 2 July 2004
- journal article
- research article
- Published by Elsevier in Experimental Neurology
- Vol. 189 (1) , 5-9
- https://doi.org/10.1016/j.expneurol.2004.05.023
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Axonal protection using flecainide in experimental autoimmune encephalomyelitisAnnals of Neurology, 2004
- Axonal L-Type Ca2+ Channels and Anoxic Injury in Rat CNS White MatterJournal of Neurophysiology, 2001
- Role of L- and N-type calcium channels in the pathophysiology of traumatic spinal cord white matter injuryNeuroscience, 2000
- Ibudilast, a phosphodiesterase inhibitor, ameliorates experimental autoimmune encephalomyelitis in Dark August ratsJournal of Neuroimmunology, 1999
- The role of voltage-gated Ca 2+ channels in anoxic injury of spinal cord white matterBrain Research, 1999
- Insights into the aetiology and pathogenesis of multiple sclerosisImmunology & Cell Biology, 1998
- [13] Murine experimental autoimmune encephalomyelitis: A model of immune-mediated inflammation and multiple sclerosisPublished by Elsevier ,1997
- Preventive but not therapeutic application of Rolipram ameliorates experimental autoimmune encephalomyelitis in Lewis ratsJournal of Neuroimmunology, 1996
- Pharmacology of bepridilThe American Journal of Cardiology, 1992
- Pathophysiological aspects of acute experimental allergic encephalomyelitisActa Neurologica Scandinavica, 1988